Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies.

Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies.

Item
http://www.wikidata.org/entity/Q38369044
Declining macrolide resistance in Streptococcus pyogenes in Portugal (2007-13) was accompanied by continuous clonal changes.Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013.Antimicrobial susceptibility of bacterial isolates from patients presenting with ear, nose and throat (ENT) infections in the German community healthcare setting.Resistance to Macrolide Antibiotics in Public Health Pathogens.Streptococcal heme binding protein (Shp) promotes virulence and contributes to the pathogenesis of group A Streptococcus infection.Immunization with Streptococcal Heme Binding Protein (Shp) Protects Mice Against Group A Streptococcus Infection.Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).Photoactivated 2,3-distyrylindoles kill multi-drug resistant bacteria.Have group A and B streptococcal infections become neglected diseases in Europe?
P2860

Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies.

Item
http://www.wikidata.org/entity/Q38369044
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies.
@en
type
label
Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies.
@en
prefLabel
Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies
@en
P2093
P2860
P304
P31
P356
10.1586/14787210.2015.1023292
P433
P478
P50
P577
P698